Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

OBJECTIVE: The aim of this study was to assess the effect of moderate or severe renal impairment on the pharmacokinetic (PK) properties of milvexian. METHODS: This open-label, parallel-group study assessed the PK, safety, and tolerability of a single oral 60 mg dose of milvexian in participants with...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Vidya, Abelian, Grigor, Li, Danshi, Wang, Zhaoqing, Zhang, Liping, Lubin, Susan, Bello, Akintunde, Murthy, Bindu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553801/
https://www.ncbi.nlm.nih.gov/pubmed/35906349
http://dx.doi.org/10.1007/s40262-022-01150-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553801/
https://www.ncbi.nlm.nih.gov/pubmed/35906349
http://dx.doi.org/10.1007/s40262-022-01150-1

Ejemplares similares